adastrahold2023-01-27T21:30:47+00:00Adastra Holdings Announces 2021 Annual Financial Results and Corporate Updateadastrahold2023-01-27T21:30:47+00:00May 4, 2022|
adastrahold2023-01-27T21:30:47+00:00Adastra Announces Submission of Medical Sales License Application and Engagement of IR Labs Inc. to Provide Investor Relations Servicesadastrahold2023-01-27T21:30:47+00:00April 12, 2022|
adastrahold2023-01-27T21:30:47+00:00Adastra Announces Successful Soft Launch of Endgame Brand in BCadastrahold2023-01-27T21:30:47+00:00April 7, 2022|
adastrahold2023-01-27T21:30:47+00:00Adastra Announces a Record Production Month and Management Changesadastrahold2023-01-27T21:30:47+00:00March 29, 2022|
adastrahold2023-01-27T21:30:47+00:00Adastra Announces Completed Submission of Controlled Substances Dealer’s License Applicationadastrahold2023-01-27T21:30:47+00:00March 25, 2022|
adastrahold2023-01-27T21:30:47+00:00Adastra Holdings Announces Co-Manufacturing Partnership to bring Zyre Brands to Marketadastrahold2023-01-27T21:30:47+00:00March 15, 2022|
adastrahold2023-01-27T21:30:47+00:00Final Adastra Holdings Expands Co-Manufacturing Portfolio and Provides Facility Expansion Updateadastrahold2023-01-27T21:30:47+00:00February 23, 2022|
adastrahold2023-01-27T21:30:47+00:00Adastra Holdings Receives Flower Sales License from Health Canadaadastrahold2023-01-27T21:30:47+00:00December 20, 2021|
